Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in rat

Cell and Tissue Research

Volumn 332, Issue 1, 2008, Pages 49-56

  Hellman, Urban ^a   Hellström, Martin ^a   Mörner, Stellan ^a   Engström Laurent, Anna ^a   Åberg, Anna Maja ^a   Oliviero, Patricia ^b   Samuel, Jane Lise ^b   Waldenström, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b INSERM   (France)

Author keywords

Cardiac hypertrophy; CD44; Extracellular matrix; Gene expression; Histochemistry; Hyaluronan synthases; Rat (Wistar, male)

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLYCOSAMINOGLYCAN; HERMES ANTIGEN; HYALURONAN SYNTHASE 1; HYALURONAN SYNTHASE 2; HYALURONAN SYNTHASE 3; HYALURONIC ACID; MESSENGER RNA; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA SURGERY; ARTICLE; CD44 GENE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; EXTRACELLULAR MATRIX; FGF 2 GENE; FGFR 1 GENE; GENE; GENE EXPRESSION; HAS1 GENE; HAS2 GENE; HAS3 GENE; HEART; HEART AFTERLOAD; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HISTOCHEMISTRY; HISTOLOGY; MALE; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; TISSUE GROWTH; WISTAR RAT; WOUND HEALING;

ANIMALS; ANTIGENS, CD44; AORTA, ABDOMINAL; CARDIOMEGALY; CONNECTIVE TISSUE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 2; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION; GLUCURONOSYLTRANSFERASE; HISTOCYTOCHEMISTRY; HYALURONIC ACID; LIGATION; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; RATS; RATS, WISTAR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

RATTUS;

EID: 41049088844     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-007-0562-8     Document Type: Article

References (40)

1. Adamia S, Maxwell CA, Pilarski LM (2005) Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord 5:3-14
2. Braunwald E (1992) Pathophysiology of heart failure. In: Braunwald E (ed) Heart disease: a textbook of cardiovascular medicine. Saunders, Philadelphia, pp 398-402
3. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro A Jr, Kubalak S, Klewer SE, McDonald JA (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106:349-360
4. Cao G, Savani RC, Fehrenbach M, Lyons C, Zhang L, Coukos G, Delisser HM (2006) Involvement of endothelial CD44 during in vivo angiogenesis. Am J Pathol 169:325-336
5. Comper WD, Laurent TC (1978) Physiological function of connective tissue polysaccharides. Physiol Rev 58:255-315
6. Corda S, Samuel JL, Rappaport L (2000) Extracellular matrix and growth factors during heart growth. Heart Fail Rev 5:119-130
7. Detillieux KA, Sheikh F, Kardami E, Cattini PA (2003) Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 57:8-19
8. Ferrans VJ (1983) Morphology of the heart in hypertrophy. Hosp Pract (Off Ed) 18:67-78
9. Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45-79
10. Goransson V, Johnsson C, Jacobson A, Heldin P, Hallgren R, Hansell P (2004) Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemia-reperfusion injury in the rat. Nephrol Dial Transplant 19:823-830
11. Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589-600
12. Hellström S, Tengblad A, Johansson C, Hedlund U, Axelsson E (1990) An improved technique for hyaluronan histochemistry using microwave irradiation. Histochem J 22:677-682
13. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274:25085-25092
14. Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, Mahdavi V (1987) Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 79:970-977
15. Jacobson A, Brinck J, Briskin MJ, Spicer AP, Heldin P (2000) Expression of human hyaluronan synthases in response to external stimuli. Biochem J 348:29-35
16. Kardami E, Jiang ZS, Jimenez SK, Hirst CJ, Sheikh F, Zahradka P, Cattini PA (2004) Fibroblast growth factor 2 isoforms and cardiac hypertrophy. Cardiovasc Res 63:458-466
17. Kuroda K, Utani A, Hamasaki Y, Shinkai H (2001) Up-regulation of putative hyaluronan synthase mRNA by basic fibroblast growth factor and insulin-like growth factor-1 in human skin fibroblasts. J Dermatol Sci 26:156-160
18. Maron BJ, Anan TJ, Roberts WC (1981) Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation 63:882-894
19. Noble PW (2002) Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21:25-29
20. Pienimaki JP, Rilla K, Fulop C, Sironen RK, Karvinen S, Pasonen S, Lammi MJ, Tammi R, Hascall VC, Tammi MI (2001) Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. J Biol Chem 276:20428-20435
21. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33-45
22. Recklies AD, White C, Melching L, Roughley PJ (2001) Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J 354:17-24
23. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93:841-842
24. Sampson PM, Rochester CL, Freundlich B, Elias JA (1992) Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J Clin Invest 90:1492-1503
25. Samuel JL, Barrieux A, Dufour S, Dubus I, Contard F, Koteliansky V, Farhadian F, Marotte F, Thiery JP, Rappaport L (1991) Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. J Clin Invest 88:1737-1746
26. Sattar A, Rooney P, Kumar S, Pye D, West DC, Scott I, Ledger P (1994) Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol 103:576-579
27. Schiaffino S, Samuel JL, Sassoon D, Lompre AM, Garner I, Marotte F, Buckingham M, Rappaport L, Schwartz K (1989) Nonsynchronous accumulation of alpha-skeletal actin and beta-myosin heavy chain mRNAs during early stages of pressure-overload-induced cardiac hypertrophy demonstrated by in situ hybridization. Circ Res 64:937-948
28. Shimabukuro Y, Ichikawa T, Takayama S, Yamada S, Takedachi M, Terakura M, Hashikawa T, Murakami S (2005a) Fibroblast growth factor-2 regulates the synthesis of hyaluronan by human periodontal ligament cells. J Cell Physiol 203:557-563
29. Shimabukuro Y, Ueda M, Ichikawa T, Terashi Y, Yamada S, Kusumoto Y, Takedachi M, Terakura M, Kohya A, Hashikawa T, Murakami S (2005b) Fibroblast growth factor-2 stimulates hyaluronan production by human dental pulp cells. J Endod 31:805-808
30. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115:2108-2118
31. Spicer AP, McDonald JA (1998) Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem 273:1923-1932
32. Swynghedauw B, Lelievre L, Charlemagne D, Chevalier B, Lauer B, Lompre AM, Mercadier JJ, Samuel JL, Schwartz K, Rappaport L (1987) Adaptational changes of sarcomere and sarcolemma during chronic cardiac overloading in rats and in humans. J Cardiovasc Pharmacol 10 (Suppl 6):S13-S19
33. Teare D (1958) Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20:1-8
34. Tengblad A (1979) Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding properties from cartilage. Biochim Biophys Acta 578:281-289
35. Towbin JA (2001) Molecular genetic basis of sudden cardiac death. Cardiovasc Pathol 10:283-295
36. Udabage L, Brownlee GR, Nilsson SK, Brown TJ (2005) The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res 310:205-217
37. van den Boom M, Sarbia M, von Wnuck Lipinski K, Mann P, Meyer-Kirchrath J, Rauch BH, Grabitz K, Levkau B, Schror K, Fischer JW (2006) Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res 98:36-44
38. Waldenström A, Schwartz K, Swynghedauw B (1989) Cardiac hypertrophy: from fetal to fatal? Clin Physiol 9:315-320
39. Waldenström A, Martinussen HJ, Gerdin B, Hallgren R (1991) Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J Clin Invest 88:1622-1628
40. Weigel PH, Hascall VC, Tammi M (1997) Hyaluronan synthases. J Biol Chem 272:13997-14000